Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10

Brain, Behavior, and Immunity

Volumn 45, Issue , 2015, Pages 80-97

  Almolda, Beatriz ^a   de Labra, Carmen ^a   Barrera, Iliana ^a   Gruart, Agnès ^b   Delgado Garcia, Jose M ^b   Villacampa, Nàdia ^a   Vilella, Antonietta ^c   Hofer, Markus J ^d   Hidalgo, Juan ^a   Campbell, Iain L ^d   González, Berta ^a   Castellano, Bernardo ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

CD11b; CD150; CD16 32; Cytokine; F4 80; GFAP; Gliosis; Iba1; IL 10R; LTP; Microglial plasticity; Neuroinflammation; Transgenic mice

Indexed keywords

CD11B ANTIGEN; CD150 ANTIGEN; CD16 ANTIGEN; CD32 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; SUPPRESSOR OF CYTOKINE SIGNALING 3; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; DIFFERENTIATION ANTIGEN; FC RECEPTOR; FCGR2B PROTEIN, MOUSE; FCGR3 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE; MESSENGER RNA; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ADULT; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CELL DENSITY; CELL FUNCTION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CEREBELLUM CORTEX; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOKINE PRODUCTION; EXPLORATORY BEHAVIOR; FUSION GENE; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIFE EXPECTANCY; LONG TERM POTENTIATION; MEMORY CONSOLIDATION; MICROGLIA; MOLECULAR BIOLOGY; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NONHUMAN; PASSIVE AVOIDANCE TEST; PHENOTYPE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PYRAMIDAL NERVE CELL; SPATIAL MEMORY; STATE DEPENDENT LEARNING; STRATUM RADIATUM; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; CEREBELLUM; CYTOLOGY; DENDRITE; GENETICS; METABOLISM; NERVE CELL; NERVE TRACT; SYNAPSE;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; ASTROCYTES; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; CALCIUM-BINDING PROTEINS; CEREBELLUM; CEREBRAL CORTEX; DENDRITES; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INTERLEUKIN-10; LONG-TERM POTENTIATION; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MICROGLIA; NEURAL PATHWAYS; NEURONS; PHENOTYPE; RECEPTORS, IGG; RNA, MESSENGER; SYNAPSES;

EID: 84924024457     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.10.015     Document Type: Article

References (80)

1. Abutbul S., Shapiro J., Szaingurten-Solodkin I., Levy N., Carmy Y., Baron R., Jung S., Monsonego A. TGF-beta signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment. Glia 2012, 60:1160-1171.
2. Almolda B., Villacampa N., Manders P., Hidalgo J., Campbell I.L., Gonzalez B., Castellano B. Effects of astrocyte-targeted production of interleukin-6 in the mouse on the host response to nerve injury. Glia 2014, 62:1142-1161.
3. Apelt J., Schliebs R. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 2001, 894:21-30.
4. Appel S.H., Beers D.R., Henkel J.S. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?. Trends Immunol. 2010, 31:7-17.
5. Arimoto T., Choi D.Y., Lu X., Liu M., Nguyen X.V., Zheng N., Stewart C.A., Kim H.C., Bing G. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol. Aging 2007, 28:894-906.
6. Bachis A., Colangelo A.M., Vicini S., Doe P.P., De Bernardi M.A., Brooker G., Mocchetti I. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 2001, 21:3104-3112.
7. Balasingam V., Yong V.W. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 1996, 16:2945-2955.
8. Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16021-16026.
9. Biber K., Owens T., Boddeke E. What is microglia neurotoxicity (not)?. Glia 2014, 62:841-854.
10. Blinzinger K., Kreutzberg G. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z. Zellforsch. Mikrosk. Anat. 1968, 85:145-157.
11. Bliss T.V., Gardner-Medwin A.R. Long-lasting potentiation of synaptic transmission in the dentate area of the unanaestetized rabbit following stimulation of the perforant path. J. Physiol. 1973, 232:357-374.
12. Boche D., Perry V.H., Nicoll J.A.R. Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol. 2013, 39:3-18.
13. Brewer K.L., Bethea J.R., Yezierski R.P. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 1999, 159:484-493.
14. Campbell I.L., Hobbs M.V., Kemper P., Oldstone M.B. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 1994, 152:716-723.
15. Cannella B., Gao Y.L., Brosnan C., Raine C.S. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 1996, 45:735-746.
16. Cannella B., Raine C.S. Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation. Ann. Neurol. 2004, 55:46-57.
17. Carson M.J., Bilousova T.V., Puntambekar S.S., Melchior B., Doose J.M., Ethell I.M. A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 2007, 4:571-579.
18. Couper K.N., Blount D.G., Riley E.M. IL-10: the master regulator of immunity to infection. J. Immunol. 2008, 180:5771-5777.
19. Crain J.M., Nikodemova M., Watters J.J. Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. J. Neurosci. Res. 2013, 91:1143-1151.
20. Cua D.J., Hutchins B., LaFace D.M., Stohlman S.A., Coffman R.L. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 2001, 166:602-608.
21. Dalmau I., Finsen B., Zimmer J., Gonzalez B., Castellano B. Development of microglia in the postnatal rat hippocampus. Hippocampus 1998, 8:458-474.
22. Dalmau I., Vela J.M., Gonzalez B., Castellano B. Expression of purine metabolism-related enzymes by microglial cells in the developing rat brain. J. Comp. Neurol. 1998, 398:333-346.
23. Dalmau I., Vela J.M., Gonzalez B., Finsen B., Castellano B. Dynamics of microglia in the developing rat brain. J. Comp. Neurol. 2003, 458:144-157.
24. Eleore L., Lopez-Ramos J.C., Yi P.J., Delgado-Garcia J.M. The cognitive enhancer T-588 partially compensates the motor associative learning impairments induced by scopolamine injection in mice. Behav. Neurosci. 2007, 121:1203-1214.
25. Ellis S.L., Gysbers V., Manders P.M., Li W., Hofer M.J., Muller M., Campbell I.L. The cell-specific induction of CXC chemokine ligand 9 mediated by IFN-gamma in microglia of the central nervous system is determined by the myeloid transcription factor PU.1. J. Immunol. 2010, 185:1864-1877.
26. Gonzalez P., Burgaya F., Acarin L., Peluffo H., Castellano B., Gonzalez B. Interleukin-10 and interleukin-10 receptor-I are upregulated in glial cells after an excitotoxic injury to the postnatal rat brain. J. Neuropathol. Exp. Neurol. 2009, 68:391-403.
27. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
28. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
29. Gruart A., Munoz M.D., Delgado-Garcia J.M. Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice. J. Neurosci. 2006, 26:1077-1087.
30. Gureviciene I., Ikonen S., Gurevicius K., Sarkaki A., van Groen T., Pussinen R., Ylinen A., Tanila H. Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice. Neurobiol. Dis. 2004, 15:188-195.
31. Harry G.J. Microglia during development and aging. Pharmacol. Ther. 2013, 139:313-326.
32. Howie D., Okamoto S., Rietdijk S., Clarke K., Wang N., Gullo C., Bruggeman J.P., Manning S., Coyle A.J., Greenfield E., Kuchroo V., Terhorst C. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood 2002, 100:2899-2907.
33. Hulshof S., Montagne L., De Groot C.J., Van Der Valk P. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 2002, 38:24-35.
34. Issazadeh S., Ljungdahl A., Hojeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J. Neuroimmunol. 1995, 61:205-212.
35. Jurado-Parras M.T., Gruart A., Delgado-Garcia J.M. Observational learning in mice can be prevented by medial prefrontal cortex stimulation and enhanced by nucleus accumbens stimulation. Learn. Memory 2012, 19:99-106.
36. Kamm K., Vanderkolk W., Lawrence C., Jonker M., Davis A.T. The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J. Trauma 2006, 60:152-157.
37. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
38. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 1998, 153:143-151.
39. Kremlev S.G., Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J. Neuroimmunol. 2005, 162:71-80.
40. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996, 19:312-318.
41. Lawson L.J., Perry V.H., Gordon S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 1992, 48:405-415.
42. Ledeboer A., Breve J.J., Poole S., Tilders F.J., Van Dam A.M. Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 2000, 30:134-142.
43. Ledeboer A., Breve J.J., Wierinckx A., van der Jagt S., Bristow A.F., Leysen J.E., Tilders F.J., Van Dam A.M. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur. J. Neurosci. 2002, 16:1175-1185.
44. Ledeboer A., Wierinckx A., Bol J.G., Floris S., Renardel de Lavalette C., De Vries H.E., van den Berg T.K., Dijkstra C.D., Tilders F.J., van dam A.M. Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE. J. Neuroimmunol. 2003, 136:94-103.
45. Li Y., Du X.F., Du J.L. Resting microglia respond to and regulate neuronal activity in vivo. Commun. Integr. Biol. 2013, 6:e24493.
46. Li Y., Du X.F., Liu C.S., Wen Z.L., Du J.L. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev. Cell 2012, 23:1189-1202.
47. Lim S.H., Park E., You B., Jung Y., Park A.R., Park S.G., Lee J.R. Neuronal synapse formation induced by microglia and interleukin 10. PLoS ONE 2013, 8:e81218.
48. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
49. Lodge P.A., Sriram S. Regulation of microglial activation by TGF-beta, IL-10, and CSF-1. J. Leukoc. Biol. 1996, 60:502-508.
50. Madronal N., Gruart A., Delgado-Garcia J.M. Differing presynaptic contributions to LTP and associative learning in behaving mice. Front. Behav. Neurosci. 2009, 3:7.
51. Madronal N., Lopez-Aracil C., Rangel A., del Rio J.A., Delgado-Garcia J.M., Gruart A. Effects of enriched physical and social environments on motor performance, associative learning, and hippocampal neurogenesis in mice. PLoS ONE 2010, 5:e11130.
52. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
53. Molina-Holgado E., Vela J.M., Arevalo-Martin A., Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 2001, 13:493-502.
54. Molina-Holgado F., Grencis R., Rothwell N.J. Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia 2001, 33:97-106.
55. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
56. Moreau-Gachelin F. Spi-1/PU.1: an oncogene of the Ets family. Biochim. Biophys. Acta 1994, 1198:149-163.
57. Navascues J., Calvente R., Marin-Teva J.L., Cuadros M.A. Entry, dispersion and differentiation of microglia in the developing central nervous system. An. Acad. Bras. Cienc. 2000, 72:91-102.
58. Norden D.M., Fenn A.M., Dugan A., Godbout J.P. TGFbeta produced by IL-10 redirected astrocytes attenuates microglial activation. Glia 2014, 62:881-895.
59. Norden D.M., Godbout J.P. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. 2013, 39:19-34.
60. Olah M., Amor S., Brouwer N., Vinet J., Eggen B., Biber K., Boddeke H.W.G.M. Identification of a microglia phenotype supportive of remyelination. Glia 2012, 60:306-321.
61. Ooboshi H., Ibayashi S., Shichita T., Kumai Y., Takada J., Ago T., Arakawa S., Sugimori H., Kamouchi M., Kitazono T., Iida M. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 2005, 111:913-919.
62. Pahl H.L., Scheibe R.J., Zhang D.E., Chen H.M., Galson D.L., Maki R.A., Tenen D.G. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J. Biol. Chem. 1993, 268:5014-5020.
63. Pang Y., Rodts-Palenik S., Cai Z., Bennett W.A., Rhodes P.G. Suppression of glial activation is involved in the protection of IL-10 on maternal E. coli induced neonatal white matter injury. Brain Res. Dev. Brain Res. 2005, 157:141-149.
64. Park K.W., Lee H.G., Jin B.K., Lee Y.B. Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo. Exp. Mol. Med. 2007, 39:812-819.
65. Perez C., Coeffier E., Moreau-Gachelin F., Wietzerbin J., Benech P.D. Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor. Mol. Cell. Biol. 1994, 14:5023-5031.
66. Prinz M., Tay T.L., Wolf Y., Jung S. Microglia: unique and common features with other tissue macrophages. Acta Neuropathol. 2014, 128:319-331.
67. Ransohoff R.M., Cardona A.E. The myeloid cells of the central nervous system parenchyma. Nature 2010, 468:253-262.
68. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
69. Rosmarin A.G., Caprio D., Levy R., Simkevich C. CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:801-805.
70. Sawada M., Suzumura A., Hosoya H., Marunouchi T., Nagatsu T. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J. Neurochem. 1999, 72:1466-1471.
71. Schilling T., Nitsch R., Heinemann U., Haas D., Eder C. Astrocyte-released cytokines induce ramification and outward K+ channel expression in microglia via distinct signalling pathways. Eur. J. Neurosci. 2001, 14:463-473.
72. Shechter R., Schwartz M. Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J. Pathol. 2013, 229:332-346.
73. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 1998, 251:189-192.
74. Stalder A.K., Carson M.J., Pagenstecher A., Asensio V.C., Kincaid C., Benedict M., Powell H.C., Masliah E., Campbell I.L. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 1998, 153:767-783.
75. Strle K., Zhou J.H., Broussard S.R., Venters H.D., Johnson R.W., Freund G.G., Dantzer R., Kelley K.W. IL-10 promotes survival of microglia without activating Akt. J. Neuroimmunol. 2002, 122:9-19.
76. Taylor M.E. Structure and function of the macrophage mannose receptor. Results Probl. Cell Differ. 2001, 33:105-121.
77. Walker F.R., Beynon S.B., Jones K.A., Zhao Z., Kongsui R., Cairns M., Nilsson M. Dynamic structural remodelling of microglia in health and disease: a review of the models, the signals and the mechanisms. Brain Behav. Immun. 2014, 37:1-14.
78. Walton M.R., Gibbons H., MacGibbon G.A., Sirimanne E., Saura J., Gluckman P.D., Dragunow M. PU.1 expression in microglia. J. Neuroimmunol. 2000, 104:109-115.
79. Xin J.P., Wainwright D.A., Mesnard N.A., Serpe C.J., Sanders V.M., Jones K.J. IL-10 within the CNS is necessary for CD4(+) T cells to mediate neuroprotection. Brain Behav. Immun. 2011, 25:820-829.
80. Zhai Q.H., Futrell N., Chen F.J. Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion. J. Neurol. Sci. 1997, 152:119-124.